<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02807350</url>
  </required_header>
  <id_info>
    <org_study_id>IXT5</org_study_id>
    <secondary_id>2U10EY011751</secondary_id>
    <nct_id>NCT02807350</nct_id>
  </id_info>
  <brief_title>Trial of Overminus Spectacle Therapy for Intermittent Exotropia</brief_title>
  <acronym>IXT5</acronym>
  <official_title>A Randomized Clinical Trial of Overminus Spectacle Therapy for Intermittent Exotropia</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Jaeb Center for Health Research</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Pediatric Eye Disease Investigator Group</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>National Eye Institute (NEI)</agency>
      <agency_class>NIH</agency_class>
    </collaborator>
  </sponsors>
  <source>Jaeb Center for Health Research</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The main objectives of this randomized trial comparing overminus lens treatment to
      non-overminus (spectacles without overminus or spectacles with plano lenses) are to
      determine:

        -  The long-term on-treatment effect of overminus treatment on distance intermittent
           exotropia (IXT) control score.

        -  The off-treatment effect of overminus treatment on distance IXT control score (following
           weaning and 3 months off treatment).
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The main objectives of this randomized trial comparing overminus lens treatment to
      non-overminus (spectacles without overminus or spectacles with plano lenses) are to
      determine:

        -  The long-term on-treatment effect of overminus treatment on distance IXT control score.

        -  The off-treatment effect of overminus treatment on distance IXT control score (following
           weaning and 3 months off treatment).

      The recently completed IXT3 pilot study (NCT02223650) addressed the question of whether
      overminus lens therapy has an initial short-term therapeutic effect for IXT while wearing
      overminus spectacles. There have been no rigorous studies that address the following
      important questions related to overminus lens therapy:

        -  Does overminus lens therapy have a long-term therapeutic effect for IXT while wearing
           overminus spectacles (over many months or years)?

        -  Does overminus lens therapy have a long-term therapeutic effect for IXT when overminus
           spectacles are discontinued?
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">January 16, 2017</start_date>
  <completion_date type="Anticipated">May 2020</completion_date>
  <primary_completion_date type="Anticipated">May 2020</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Mean Distance Control at 12-Months (On-Treatment Visit)</measure>
    <time_frame>12 months</time_frame>
    <description>A comparison of mean control of the distance exodeviation (average of 3 measurements over the exam) between the 2.50 diopters (D) overminus group and the non-overminus group (spectacles without overminus or no spectacles) at 12 months.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Mean Distance Control at 18-Months (Off-Treatment Visit)</measure>
    <time_frame>18 months</time_frame>
    <description>A comparison of mean control of the distance exodeviation (average of 3 measurements over the exam) between the 2.50D overminus group and the non-overminus group (spectacles without overminus or no spectacles) at 18 months (after treatment discontinuation).</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>No Spontaneous Tropia</measure>
    <time_frame>At 12 months and 18 months</time_frame>
    <description>The proportion of subjects with no spontaneous tropia at 12 months and at 18 months will be compared between treatment groups.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in Distance Control</measure>
    <time_frame>At 12 months and 18 months</time_frame>
    <description>The proportion of subjects with ≥1 point improvement in distance control between baseline and 12 months and between baseline and 18 months will be compared between treatment groups. The proportion of subjects with ≥2 points improvement in distance control will be similarly compared between treatment groups.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Deterioration as assessed by motor alignment and stereoacuity at near</measure>
    <time_frame>At 12 months and 18 months</time_frame>
    <description>The cumulative proportion of subjects who meet deterioration criteria by the time point will be estimated for each treatment group.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Near Control</measure>
    <time_frame>At 12 months and 18 months</time_frame>
    <description>A comparison of mean control of the near exodeviation (average of 3 measurements over the exam) between the 2.50D overminus group and the non-overminus group (spectacles without overminus or no spectacles) at each timepoint.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in Near Control</measure>
    <time_frame>At 12 months and 18 months</time_frame>
    <description>For each timepoint, the proportion of subjects with ≥1 point improvement in near control since baseline will be compared between treatment groups. The proportion of subjects with ≥2 points improvement in near control will be similarly compared.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Angle magnitude</measure>
    <time_frame>At 12 months and 18 months</time_frame>
    <description>The magnitude of the deviation by Prism Alternate Cover Test (PACT) will be compared between treatment groups.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Stereoacuity</measure>
    <time_frame>At 12 months and 18 months</time_frame>
    <description>A comparison of near stereoacuity will be assessed using the Randot Preschool stereotest at near (performed at 40 cm) between treatment groups.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Compliance with Spectacle Wear</measure>
    <time_frame>At 6 months and 12 months</time_frame>
    <description>Compliance with spectacle wear will be assessed at the 6-month and 12-month outcome exam. Parents will give an estimate of the proportion of the time their children wore their spectacles. Proportion of time worn will be described as excellent (76% to 100%), good (51% to 75%), fair (26% to 50%), or poor (≤ 25%). The distribution of compliance will be assessed for each treatment group at the outcome exam.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Symptom survey</measure>
    <time_frame>At 12 months and 18 months</time_frame>
    <description>A brief survey of symptoms that may be associated with overminus such as headaches, eye strain, and problems with spectacle wear will be administered to the parents of the subjects. Parents are asked to respond to the survey questions based on their observations of their child in the past 2 weeks. Response options are based on frequency of observations; never, rarely, sometimes, often, always, and not applicable.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">384</enrollment>
  <condition>Intermittent Exotropia</condition>
  <arm_group>
    <arm_group_label>Overminus Treatment</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>spectacles with full cycloplegic refraction plus 2.50 D overminus added to the sphere</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Non-overminus Treatment</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>spectacles with full cycloplegic refraction without overminus</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Overminus treatment</intervention_name>
    <description>spectacles with full cycloplegic refraction plus 2.50 D overminus added to the sphere</description>
    <arm_group_label>Overminus Treatment</arm_group_label>
    <other_name>Overminus spectacles</other_name>
    <other_name>Overminus glasses</other_name>
    <other_name>Overminus therapy</other_name>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Non-overminus treatment</intervention_name>
    <description>spectacles with full cycloplegic refraction without overminus</description>
    <arm_group_label>Non-overminus Treatment</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Age 3 years to &lt; 11 years

          -  Intermittent exotropia (manifest deviation) meeting all of the following criteria:

          -  At distance: intermittent exotropia or constant exotropia

             o Mean distance control score of 2 points or more (mean of 3 assessments over the
             exam)

          -  At near: intermittent exotropia, exophoria, or orthophoria

             o Subject cannot have a score of 5 points on all 3 near assessments of control

          -  Exodeviation at least 15∆ at distance measured by PACT

          -  Near deviation does not exceed distance deviation by more than 10∆ by PACT
             (convergence insufficiency type IXT excluded)

          -  Distance visual acuity (any optotype method) in each eye of 0.4 logMAR (20/50) or
             better if age 3 years and 0.3 logMAR (20/40) or better if 4 years or older.

          -  Interocular difference of distance visual acuity ≤0.2 logMAR (2 lines on a logMAR
             chart)

          -  Refractive error between -6.00 diopters (D) standard error (SE) and +1.00D SE
             (inclusive) in the most myopic / least hyperopic eye based on a cycloplegic refraction
             performed within the past 2 months or at the end of the enrollment exam.

          -  If refractive error (based on cycloplegic refraction performed within past 2 months or
             at the end of the enrollment exam) meets any of the following criteria, then pre-study
             spectacles are required and must have been worn for at least 1 week prior to
             enrollment:

          -  SE anisometropia ≥1.00D

          -  Astigmatism ≥1.50D in either eye

          -  SE myopia ≥-1.00D in either eye

        Pre-study refractive correction, if worn, must meet the following criteria relative to the
        cycloplegic refraction performed within past 2 months or at the end of the enrollment exam:

          -  SE anisometropia must be corrected within &lt;1.00D of the SE anisometropic difference

          -  Astigmatism must be corrected within &lt;1.00D of full magnitude; axis must be within 10
             degrees.

          -  The SE of the spectacles must not meet the definition of substantial overminus (see
             exclusion criteria below)

          -  Gestational age ≥ 32 weeks

          -  Birth weight &gt; 1500 grams

          -  Parent understands the protocol and is willing to accept randomization to overminus
             spectacles or non-overminus spectacles

          -  Parent has home phone (or access to phone) and is willing to be contacted by Jaeb
             Center staff and Investigator's site staff

          -  Relocation outside of area of an active PEDIG site within next 18 months is not
             anticipated

        Exclusion Criteria:

          -  Treatment for IXT or amblyopia (other than refractive correction) within the past 4
             weeks, including vision therapy, patching, atropine, or other penalization.

          -  Current contact lens wear

          -  Substantial deliberate overminus treatment within the past 6 months, defined as
             spectacles overminused by more than 1.00D SE than the cycloplegic refractive error
             (within 2 months or at the end of the enrollment exam)

          -  Prior strabismus, intraocular, or refractive surgery (including BOTOX injection)

          -  Abnormality of the cornea, lens, or central retina

          -  Down syndrome or cerebral palsy

          -  Severe developmental delay which would interfere with treatment or evaluation (in the
             opinion of the investigator). Subjects with mild speech delays or reading and/or
             learning disabilities are not excluded.

          -  Any disease known to affect accommodation, vergence, and ocular motility such as
             multiple sclerosis, Graves orbitopathy, dysautonomia, myasthenia gravis, or current
             use of atropine for amblyopia

          -  Anti-seizure medications [e.g., carbamazepine (Tegretol, Carbatrol, Epitol, or
             Equetro), diazepam (Valium or Diastat), clobazam (Frisium or Onfri), clonazepam
             (Klonopin), lorazepam (Ativan), ethosuximide (Zarontin), felbamate (Felbatol),
             lacosamide (VIMPAT), gabapentin (Neurontin), oxcarbazepine (Oxtellar XR or Trileptal),
             phenobarbital, phenytoin (Dilantin or Phenytek), pregabalin (Lyrica), tiagabine
             (Gabitril), topiramate (Topamax), valproate (Depakote), or zonisamide (Zonegran),
             vigabatrin (Sabril)]
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>3 Years</minimum_age>
    <maximum_age>10 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Angela M Chen, OD, MS</last_name>
    <role>Study Chair</role>
    <affiliation>Marshall B. Ketchum University</affiliation>
  </overall_official>
  <overall_official>
    <last_name>S. Ayse Erzurum, MD</last_name>
    <role>Study Chair</role>
    <affiliation>Eye Care Associates, Inc.</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Raymond T Kraker, MSPH</last_name>
    <phone>813-975-8690</phone>
    <email>rkraker@jaeb.org</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Jennifer Shah</last_name>
    <phone>813-975-8690</phone>
    <email>pedig@jaeb.org</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Midwestern University Eye Institute</name>
      <address>
        <city>Glendale</city>
        <state>Arizona</state>
        <zip>85308</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Alicia Feis, OD</last_name>
      <phone>623-806-7271</phone>
      <email>afeis@midwestern.edu</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>University Eye Center at Ketchum Health</name>
      <address>
        <city>Anaheim</city>
        <state>California</state>
        <zip>92807</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Susan Cotter, OD, MS</last_name>
      <phone>714-449-7488</phone>
      <email>scotter@ketchum.edu</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Marshall B. Ketchum University</name>
      <address>
        <city>Fullerton</city>
        <state>California</state>
        <zip>92831</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Angela Chen, O.D., M.S.</last_name>
      <phone>714-449-7432</phone>
      <email>angelachen@ketchum.edu</email>
    </contact>
    <investigator>
      <last_name>Angela Chen, O.D., M.S.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Western University College of Optometry</name>
      <address>
        <city>Pomona</city>
        <state>California</state>
        <zip>91766</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Ida Chung, OD</last_name>
      <phone>909-469-8687</phone>
      <email>ichung@westernu.edu</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>University of California, Davis Department of Ophthalmology</name>
      <address>
        <city>Sacramento</city>
        <state>California</state>
        <zip>95817</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Mary O'Hara, MD</last_name>
      <phone>916-734-8755</phone>
      <email>maohara@ucdavis.edu</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>University of California San Francisco Department of Ophthalmology</name>
      <address>
        <city>San Francisco</city>
        <state>California</state>
        <zip>94143</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Alejandra de Alba Campomanes, MD</last_name>
      <phone>415-353-2560</phone>
      <email>dealbaa@vision.ucsf.edu</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Nova Southeastern University College of Optometry, The Eye Institute</name>
      <address>
        <city>Fort Lauderdale</city>
        <state>Florida</state>
        <zip>33382</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Cristina Law, OD</last_name>
      <phone>954-262-1426</phone>
      <email>lcristin@nova.edu</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Nemours Children's Clinic</name>
      <address>
        <city>Jacksonville</city>
        <state>Florida</state>
        <zip>32207</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>John Erickson, OD</last_name>
      <phone>904-697-3775</phone>
      <email>john.erickson@nemours.org</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>The Emory Eye Center</name>
      <address>
        <city>Atlanta</city>
        <state>Georgia</state>
        <zip>30322</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jason Peragallo, MD</last_name>
      <phone>404-778-4725</phone>
      <email>jperaga@emory.edu</email>
    </contact>
    <contact_backup>
      <last_name>Amy Hutchinson, MD</last_name>
      <phone>(404) 778-4725</phone>
      <email>amy.hutchinson@emory.edu</email>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>St Luke's Hospital</name>
      <address>
        <city>Boise</city>
        <state>Idaho</state>
        <zip>83702</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Katherine Lee, MD</last_name>
      <phone>208-381-6910</phone>
      <email>leek@slhs.org</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>The Eye Specialists Center, LLC</name>
      <address>
        <city>Chicago Ridge</city>
        <state>Illinois</state>
        <zip>60415</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Benjamin Ticho</last_name>
      <phone>708-423-4070</phone>
      <email>Bticho@mac.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Ann &amp; Robert H. Lurie Children's Hospital of Chicago</name>
      <address>
        <city>Chicago</city>
        <state>Illinois</state>
        <zip>60611</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Bahram Rahmani, MD</last_name>
      <phone>312-227-6189</phone>
      <email>BRahmani@luriechildrens.org</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Illinois College of Optometry</name>
      <address>
        <city>Chicago</city>
        <state>Illinois</state>
        <zip>60616</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Yi Pang, OD, PhD</last_name>
      <phone>312-949-7287</phone>
      <email>ypang@ico.edu</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Pediatric Eye Associates</name>
      <address>
        <city>Wilmette</city>
        <state>Illinois</state>
        <zip>60091</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Lisa Verderber, MD</last_name>
      <phone>847-256-2020</phone>
      <email>l.verderber@worldnet.att.net</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Indiana University School Of Optometry</name>
      <address>
        <city>Bloomington</city>
        <state>Indiana</state>
        <zip>47405</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Don Lyon</last_name>
      <phone>317-856-1964</phone>
      <email>dwlyon@indiana.edu</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>The Eye Specialist Center, LLC</name>
      <address>
        <city>Munster</city>
        <state>Indiana</state>
        <zip>46321</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Birva Shah, OD</last_name>
      <phone>219-836-7990</phone>
      <email>birva14@gmail.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Wolfe Eye Clinic</name>
      <address>
        <city>West Des Moines</city>
        <state>Iowa</state>
        <zip>50266</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Derek Bitner, MD</last_name>
      <phone>800-542-7957</phone>
      <email>dbitner@wolfeclinic.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>University of Kentucky Department of Neurology</name>
      <address>
        <city>Lexington</city>
        <state>Kentucky</state>
        <zip>40536</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Christi Willen, MD</last_name>
      <phone>859-323-5867</phone>
      <email>christiwillen@uky.edu</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Greater Baltimore Medical Center</name>
      <address>
        <city>Baltimore</city>
        <state>Maryland</state>
        <zip>21204-5809</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Mary Louise Collins, MD</last_name>
      <phone>443-849-8082</phone>
      <email>mcollins@gbmc.org</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Wilmer Eye Institute</name>
      <address>
        <city>Baltimore</city>
        <state>Maryland</state>
        <zip>21287-9028</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Michael X Repka, MD</last_name>
      <phone>410-955-8314</phone>
      <email>mrepka@jhmi.edu</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Boston Medical Center</name>
      <address>
        <city>Boston</city>
        <state>Massachusetts</state>
        <zip>02118</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Stephen Christiansen, MD</last_name>
      <phone>617-414-2020</phone>
      <email>spchris@bu.edu</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Center for Eye Health, Inc.</name>
      <address>
        <city>Fall River</city>
        <state>Massachusetts</state>
        <zip>02720</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>John Donahue, MD, PhD</last_name>
      <phone>508-235-6216</phone>
      <email>jdonahuemd@yahoo.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Eye and Vision Center at MCPHS University</name>
      <address>
        <city>Worcester</city>
        <state>Massachusetts</state>
        <zip>01608</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Kathleen O'Leary, OD</last_name>
      <phone>508-373-5830</phone>
      <email>kathleen.oleary@mcphs.edu</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Helen DeVos Children's Hospital Pediatric Ophthalmology</name>
      <address>
        <city>Grand Rapids</city>
        <state>Michigan</state>
        <zip>49503</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Brooke Geddie, DO</last_name>
      <phone>616-267-2605</phone>
      <email>brooke.geddie@helendevoschildrens.org</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Pediatric Ophthalmology, P.C.</name>
      <address>
        <city>Grand Rapids</city>
        <state>Michigan</state>
        <zip>49546</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Patrick Droste, MD</last_name>
      <phone>616-957-0866</phone>
      <email>drdroste@comcast.net</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Children's Eye Care PC</name>
      <address>
        <city>West Bloomfield Township</city>
        <state>Michigan</state>
        <zip>48322</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Lisa Bohra, MD</last_name>
      <phone>248-254-8140</phone>
      <email>lisabohra@hotmail.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Mayo Clinic Department of Ophthalmology</name>
      <address>
        <city>Rochester</city>
        <state>Minnesota</state>
        <zip>55905</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jonathan M. Holmes, M.D.</last_name>
      <phone>507-284-3760</phone>
      <email>holmes.jonathan@mayo.edu</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Children's Mercy Hospitals and Clinics</name>
      <address>
        <city>Kansas City</city>
        <state>Missouri</state>
        <zip>64108</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Justin Marsh, MD</last_name>
      <phone>816-701-1337</phone>
      <email>jdmarsh@cmh.edu</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>University of Nebraska Medical Center</name>
      <address>
        <city>Omaha</city>
        <state>Nebraska</state>
        <zip>68114</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Donny Suh, MD</last_name>
      <phone>402-559-2977</phone>
      <email>dsuh@childrensomaha.org</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Concord Ophthalmologic Associates</name>
      <address>
        <city>Concord</city>
        <state>New Hampshire</state>
        <zip>03301</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Christie Morse, MD</last_name>
      <phone>603-224-2020</phone>
      <phone_ext>2137</phone_ext>
      <email>cmorse@crhc.org</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>State University of New York, College of Optometry</name>
      <address>
        <city>New York</city>
        <state>New York</state>
        <zip>10036</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Marilyn Vricella, OD</last_name>
      <phone>212-780-5182</phone>
      <email>mvricella@sunyopt.edu</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Family Eye Care of the Carolinas</name>
      <address>
        <city>Aberdeen</city>
        <state>North Carolina</state>
        <zip>28315</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Michael Bartiss, MD</last_name>
      <phone>910-235-3700</phone>
      <email>kidseyes@earthlink.net</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Cincinnati Children's Hospital</name>
      <address>
        <city>Cincinnati</city>
        <state>Ohio</state>
        <zip>45229</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Michael Gray, MD</last_name>
      <phone>513-636-4751</phone>
      <email>Michael.Gray@cchmc.org</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>The Ohio State University College of Optometry</name>
      <address>
        <city>Columbus</city>
        <state>Ohio</state>
        <zip>43210-1280</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Marjean Kulp, OD, MS</last_name>
      <phone>614-688-3336</phone>
      <email>MTkulp@optometry.osu.edu</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Eye Care Associates, Inc.</name>
      <address>
        <city>Poland</city>
        <state>Ohio</state>
        <zip>44514</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>S. Ayse Erzurum, M.D.</last_name>
      <phone>330-746-7691</phone>
      <email>erzurum2020@gmail.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Pacific University College of Optometry</name>
      <address>
        <city>Portland</city>
        <state>Oregon</state>
        <zip>97205</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Richard London, OD</last_name>
      <phone>503-224-2323</phone>
      <email>LondonR@pacificu.edu</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Casey Eye Institute</name>
      <address>
        <city>Portland</city>
        <state>Oregon</state>
        <zip>97239</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Allison Summers, OD</last_name>
      <phone>503-494-7830</phone>
      <email>summersa@ohsu.edu</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Pediatric Ophthalmology of Erie</name>
      <address>
        <city>Erie</city>
        <state>Pennsylvania</state>
        <zip>16501</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Nicholas A Sala, D.O.</last_name>
      <phone>814-454-6307</phone>
      <email>nasala@kidseyeserie.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Conestoga Eye</name>
      <address>
        <city>Lancaster</city>
        <state>Pennsylvania</state>
        <zip>17601</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>David Silbert, MD</last_name>
      <phone>717-541-9700</phone>
      <email>davidsilbertmd@gmail.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Salus University/Pennsylvania College of Optometry</name>
      <address>
        <city>Philadelphia</city>
        <state>Pennsylvania</state>
        <zip>19141</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Erin Jenewein, OD</last_name>
      <phone>215-276-6000</phone>
      <email>Ejenewein@salus.edu</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>UPMC Children's Eye Center of Children's Hospital of Pittsburgh</name>
      <address>
        <city>Pittsburgh</city>
        <state>Pennsylvania</state>
        <zip>15224</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Ken Nischal, MD</last_name>
      <phone>412-692-5918</phone>
      <email>nischalkk@upmc.edu</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Medical University of South Carolina, Storm Eye Institute</name>
      <address>
        <city>Charleston</city>
        <state>South Carolina</state>
        <zip>29425</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Edward Cheeseman, MD</last_name>
      <phone>843-792-2903</phone>
      <email>cheesema@musc.edu</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Pediatric Eye Specialists</name>
      <address>
        <city>Chattanooga</city>
        <state>Tennessee</state>
        <zip>37421</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Edward Peterson, MD</last_name>
      <phone>423-648-1020</phone>
      <email>eap51949@gmail.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Southern College of Optometry</name>
      <address>
        <city>Memphis</city>
        <state>Tennessee</state>
        <zip>38104</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Marie Bodack, OD</last_name>
      <phone>901-722-3276</phone>
      <email>mbodack@sco.edu</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>University of Texas- Robert Cizik Eye Clinic</name>
      <address>
        <city>Houston</city>
        <state>Texas</state>
        <zip>77030</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Megan Geloneck, MD</last_name>
      <phone>713-500-7943</phone>
      <email>megangeloneck@cizikeye.org</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>University of Houston College of Optometry</name>
      <address>
        <city>Houston</city>
        <state>Texas</state>
        <zip>77204</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Ruth Manny, OD, PhD</last_name>
      <phone>713-743-1944</phone>
      <email>rmanny@central.uh.edu</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>University of Incarnate Word Rosenberg School of Optometry</name>
      <address>
        <city>San Antonio</city>
        <state>Texas</state>
        <zip>78229</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Kara Tison, OD</last_name>
      <phone>210-283-6881</phone>
      <email>ktison@uiwtx.edu</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Houston Eye Associates</name>
      <address>
        <city>The Woodlands</city>
        <state>Texas</state>
        <zip>77381</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Aaron Miller, MD</last_name>
      <phone>281-351-5468</phone>
      <email>AMiller@HoustonEye.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Rocky Mountain Eye Care Associates</name>
      <address>
        <city>Salt Lake City</city>
        <state>Utah</state>
        <zip>84107</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>David Petersen, MD</last_name>
      <phone>801-264-4450</phone>
      <email>dpetersen@rmeyecare.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Virginia Pediatric Eye Center</name>
      <address>
        <city>Norfolk</city>
        <state>Virginia</state>
        <zip>23502</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Eric Crouch, MD</last_name>
      <phone>757-461-0050</phone>
      <email>ercrouch@gmail.com</email>
    </contact>
    <contact_backup>
      <last_name>Earl Crouch, MD</last_name>
      <phone>(757) 461-0050</phone>
      <email>earl.crouch@virginiapediatriceye.com</email>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>Marshall University</name>
      <address>
        <city>Scott Depot</city>
        <state>West Virginia</state>
        <zip>25560</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Deborah Klimek, MD</last_name>
      <phone>304-691-8901</phone>
      <email>klimekdl@yahoo.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>CHU - Sainte-Justine</name>
      <address>
        <city>Montreal</city>
        <state>Quebec</state>
        <zip>H3T 1C5</zip>
        <country>Canada</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Rosanne Superstein, MD</last_name>
      <phone>514-345-4715</phone>
      <email>rosanne.superstein@mcgill.ca</email>
    </contact>
  </location>
  <location_countries>
    <country>Canada</country>
    <country>United States</country>
  </location_countries>
  <link>
    <url>http://pedig.jaeb.org/</url>
    <description>PEDIG public website</description>
  </link>
  <verification_date>October 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>June 16, 2016</study_first_submitted>
  <study_first_submitted_qc>June 16, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">June 21, 2016</study_first_posted>
  <last_update_submitted>October 27, 2017</last_update_submitted>
  <last_update_submitted_qc>October 27, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">October 31, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Intermittent Exotropia</keyword>
  <keyword>IXT</keyword>
  <keyword>overminus</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Exotropia</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Mydriatics</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>Yes</sharing_ipd>
    <ipd_description>In accordance with the NIH data sharing policy, a de-identified database is placed in the public domain on the PEDIG public website after the completion of each protocol and publication of the primary manuscript.</ipd_description>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

